Lombard moving to America

Medical devices company Lombard Medical Technologies is planning to leave the London stock market and rehome with an initial public offering on Nasdaq worth up to $80m. The decision by the Aim-listed company, which specialises in the repair of aneurysms, reflects the attraction of the US market for small medical companies, following an exceptionally strong run in biotech stocks in the past two years. Jefferies and Barclays are bookrunners.